The hepatitis B virus X protein promotes hepatocellular carcinoma metastasis by upregulation of matrix metalloproteinases
✍ Scribed by Di-Peng Ou; Yi-Ming Tao; Fa-Qing Tang; Lian-Yue Yang
- Book ID
- 102863239
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- French
- Weight
- 507 KB
- Volume
- 120
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The hepatitis B virus (HBV) is a major cause of human hepatocellular carcinoma (HCC) which has a very high mortality rate due to high incidence of metastasis. It is unknown whether HBV contributes to HCC metastasis. In this report, we present clinical data obtained from HCC patients indicating that the expression of hepatitis B virus X protein (HBx) in HCC is associated with an increased expression of membrane‐type 1 matrix metalloproteinase (MT1‐MMP), and matrix metalloproteinase‐2(MMP‐2), which correlates with a poor prognosis. We further demonstrate experimentally that HBx upregulates MT1‐MMP, which in turn induces MMP‐2. Significantly, HBx‐mediated MMP activation is associated with a marked increase of cell migration, as revealed by both wound‐healing and transwell migration assays, suggesting that HBx may facilitate tumor cell invasion by upregulation of MMPs and subsequent destruction of the extracellular matrix. Together, our results support a model in which HBx contributes to HCC metastasis by upregulation of MMPs. © 2006 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Hepatitis B virus (HBV) X protein (HBx) and cyclooxygenase‐2 (COX‐2) are all playing roles in hepatocellular carcinoma (HCC), but the reversing effects of COX‐2 inhibitors on the neoplastic features caused by HBx protein is still unclear. To further evaluate the therapeutic potential of